Aptamer launches cost-cutting blitz as it targets break-even

Aptamer Group PLC on Thursday announced a cost-cutting drive as it aims to break even within two years.

The York-based biotech firm that makes synthetic antibodies capable of binding to targets such...

Related Keywords

Rob Quinn , Ian Gilham , Arron Tolley , David Bunka , Alastair Fleming , Jeremy Cutler , Andrew Rapson , Alliance News Ltd , Aptamer Group , Alliance News , Stephen Hull , Co Founder Arron Tolley , All Rights , Markets ,